-
Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Alcohol Abuse and Alcoholism Special Emphasis Panel, Preclinical Medications Screening in Dependence Models of Alcohol Use Disorders.
Date: November 1, 2024.
Time: 2:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institute of Health, National Institute on Alcohol Abuse and Alcoholism, 6700B Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Ranga V. Srinivas, Ph.D., Chief, Extramural Project Review Branch, National Institute on Alcohol Abuse and Alcoholism, 6700 B Rockledge Drive, Room 2114, National Institutes of Health, Bethesda, MD 20892, (301) 451-2067, srinivar@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.273, Alcohol Research Programs, National Institutes of Health, HHS)
Dated: October 3, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-23321 Filed 10-8-24; 8:45 am]
BILLING CODE 4140-01-P
Document Information
- Published:
- 10/09/2024
- Department:
- National Institutes of Health
- Entry Type:
- Notice
- Document Number:
- 2024-23321
- Dates:
- November 1, 2024.
- Pages:
- 81925-81925 (1 pages)
- PDF File:
- 2024-23321.pdf